Please note: the ACC uses a January - December calendar, which is indicated in the estimated release dates below. The policies appear in order based on their estimated release date.

Inflammation is a key contributor to cardiovascular disease (CVD), influencing both its onset and progression. High-sensitivity C-reactive protein (hsCRP) serves as a reliable biomarker for detecting ...

During ACC's 75th Anniversary, we're celebrating our legacy and preparing to shape the next 75 years. Help us invest in the future of cardiology with a gift to the ACC Foundation. Gifts support a ...

WASHINGTON (July 28, 2014) — Running for only a few minutes a day or at slow speeds may significantly reduce a person’s risk of death from cardiovascular disease compared to someone who does not run, ...

Lipoprotein(a) (Lp[a]) is a low-density lipoprotein–like molecule with an apolipoprotein (b) moiety that is covalently attached to apolipoprotein (a) (Apo[a]), a plasminogen-like protein that confers ...

Sorry to break your heart. You might find something similar through our search. Please try again.

Centers for Disease Control and Prevention (CDC) data shows an alarming increase in obesity among the United States (US) population, from 30.5% in 2000 to 42.4% in 2018. The combination of overweight ...

The following are key points to remember from the 2022 European Society of Cardiology/European Respiratory Society (ESC/ERS) guidelines for the diagnosis and treatment of pulmonary hypertension: ...

New guidance from the U.S. Preventive Service Task Force (USPSTF) recommends against initiating the use of low-dose aspirin in patients over 60 years of age for primary prevention of atherosclerotic ...